NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016
Press Release
Read More
MLL: The gene and its translocation partners. 2 cases with a t(11;17) involving MLL and mimicking the variant t(11;17) RARA translocation
Literature
Read More
PD-L1 expression correlates with TP53 gene mutation status in lung cancer but not in colorectal cancer
Literature
Read More
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Literature
Read More
Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome
Literature
Read More
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism
Literature
Read More
NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains
Press Release
Read More